| Bid Price | 2018.00p | High Price | 2026.00p |
|---|
| Ask Price | 2020.00p | Low Price | 1995.00p |
|---|
| Open Price | 1995.00p | Spread | 0.10% |
|---|
| Prev Close | 1999.00p | Volume | 277,443 |
|---|
Hikma Pharmaceuticals PLC Historic Prices
| Date | Open | High | Low | Close | Volume |
|---|
| Jun 27, 2025 | 1995.00 | 2026.00 | 1995.00 | 2026.00 | 277,443 |
| Jun 26, 2025 | 2028.00 | 2034.00 | 1986.00 | 1999.00 | 1,046,258 |
| Jun 25, 2025 | 2058.00 | 2072.00 | 2020.00 | 2036.00 | 362,568 |
| Jun 24, 2025 | 2068.00 | 2074.00 | 2056.00 | 2062.00 | 355,021 |
| Jun 23, 2025 | 2044.00 | 2064.00 | 2040.00 | 2048.00 | 400,006 |
Hikma Pharmaceuticals PLC Information
| Name | Hikma Pharmaceuticals PLC | Index | FTSE 100 |
|---|
| ISIN | GB00B0LCW083 | Epic | HIK |
|---|
| Type | Equity | Currency | GBX |
|---|
| Record Status | Active | Trading Segment | SET1 |
|---|
| Industry | Drug Manufacturers - Specialty & Generic | Sector | Healthcare |
|---|
| EMS | 500 | Trading Status | Closed |
|---|
| Shares in Issue | 220.43 m | Prev Close | 1999.00p |
|---|
| PE Ratio | 17.269711 | Market Cap | £4.47 bn |
|---|
| Div Yield | 3.03 | Div per Share | $0.32 |
|---|
| EPS | $0.60 | Div Cover | 1.8834 |
|---|
| PEG | n/a | EPS Growth (%) | 0.00 |
|---|
| ROCE | 0.042827 | DPS Growth (%) | 0.2735 |
|---|
| Current Ratio | 1.144085 | Quick Ratio | 0.565217 |
|---|
Hikma Pharmaceuticals PLC Director Deals
| Declared | Type | Director | Pos. | Volume / Price | Value |
|---|
| 03/06/25 | TIN | Mazen Darwazah | CH | 36,171 @ £0.00 | £0.00 |
| 03/06/25 | TIN | Said Darwazah | CEO | 31,679 @ £0.00 | £0.00 |
| 03/06/25 | SELL | Riad Mishlawi | CEO | 13,863 @ £21.38 | £296,391.00 |
| 03/06/25 | TIN | Riad Mishlawi | CEO | 36,371 @ £0.00 | £0.00 |
| 08/05/25 | DRIP | Riad Mishlawi | CEO | 1,454 @ £20.23 | £29,414.00 |
| 04/03/25 | TIN | Mazen Darwazah | CH | 14,844 @ £0.00 | £0.00 |
| 04/03/25 | TIN | Said Darwazah | CEO | 18,420 @ £0.00 | £0.00 |
| 04/03/25 | EXR | Riad Mishlawi | CEO | 19,890 @ £0.00 | £0.00 |
| 04/03/25 | TIN | Riad Mishlawi | CEO | 18,691 @ £0.00 | £0.00 |
| 24/09/24 | DRIP | Riad Mishlawi | CEO | 509 @ £19.03 | £9,686.00 |
Hikma Pharmaceuticals PLC News
